Mesoblast
MESO
$2.27
Share price
-0.44%
Change (1 day)
-70.63%
Change (1 year)
Categories
Revenue for Mesoblast (MESO)
Revenue in 2021 (TTM): $9.93 M
According to Mesoblast 's latest financial reports the company's current revenue (TTM) is $9.98 M. In 2020 the company made a revenue of $0.01 B a decrease over the years 2019 revenue that were of $0.02 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Mesoblast from 2015 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | $9.93 M | -38.9% |
| 2020 | $0.01 B | -23.83% |
| 2019 | $0.02 B | 32.59% |
| 2018 | $0.01 B | 1.06% |
| 2017 | $0.01 B | -50.18% |
| 2016 | $0.03 B | 33.57% |
| 2015 | $0.02 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | N/A | -100.00% | Bahamas |